Robert J. Mulroy

2012

In 2012, Robert J. Mulroy earned a total compensation of $4M as President and Chief Executive Officer at Merrimack Pharmaceuticals, a 414% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$222,750
Option Awards$3,322,500
Salary$465,820
Other$12,522
Total$4,023,592

Mulroy received $3.3M in option awards, accounting for 83% of the total pay in 2012.

Mulroy also received $222.8K in non-equity incentive plan, $465.8K in salary and $12.5K in other compensation.

Rankings

In 2012, Robert J. Mulroy's compensation ranked 1,629th out of 11,487 executives tracked by ExecPay. In other words, Mulroy earned more than 85.8% of executives.

ClassificationRankingPercentile
All
1,629
out of 11,487
86th
Division
Manufacturing
584
out of 4,253
86th
Major group
Chemicals And Allied Products
129
out of 1,198
89th
Industry group
Drugs
69
out of 920
93rd
Industry
Pharmaceutical Preparations
58
out of 700
92nd
Source: SEC filing on March 27, 2015.

Mulroy's colleagues

We found four more compensation records of executives who worked with Robert J. Mulroy at Merrimack Pharmaceuticals in 2012.

2012

Ulrik Nielsen

Merrimack Pharmaceuticals

Chief Scientific Officer

2012

William McClements

Merrimack Pharmaceuticals

Head of Corporate Operations

2012

Edward Stewart

Merrimack Pharmaceuticals

Senior Vice President and President, Merrimack Healthcare Solutions

2012

William Sullivan

Merrimack Pharmaceuticals

Chief Financial Officer

In-depth

You may also like